Your browser doesn't support javascript.

Portal de Pesquisa da BVS

Informação e Conhecimento para a Saúde

Home > Pesquisa > ()
XML
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Elimination of rubella and congenital rubella syndrome in the Americas.

Castillo-Solórzano, Carlos; Marsigli, Christina; Bravo-Alcántara, Pamela; Flannery, Brendan; Ruiz Matus, Cuauhtémoc; Tambini, Gina; Gross-Galiano, Socorro; Andrus, Jon Kim.
J Infect Dis; 204 Suppl 2: S571-8, 2011 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-21954249
In 2003, the Pan American Health Organization (PAHO) adopted a resolution calling for rubella and congenital rubella syndrome (CRS) elimination in the Americas by the year 2010. To accomplish this goal, PAHO advanced a rubella and CRS elimination strategy including introduction of rubella-containing vaccines into routine vaccination programs accompanied by high immunization coverage, interruption of rubella transmission through mass vaccination of adolescents and adults, and strengthened surveillance for rubella and CRS. The rubella elimination strategies were aligned with the successful measles elimination strategies. By the end of 2009, all countries routinely vaccinated children against rubella, an estimated 450 million people had been vaccinated against measles and rubella in supplementary immunization activities, and rubella transmission had been interrupted. This article describes how the region eliminated rubella and CRS.